“A REVIEW ON THE PHARMACEUTICAL ANALYTICAL PROFILE OF AN ANTIVIRAL DRUG: REMDESIVIR”. 2022. Journal of Pharmaceutical Negative Results, November, 217-25. https://doi.org/10.47750/pnr.2022.13.S09.026.